Review
Accepted on 12 Nov 2024
New insights into SUMOylation and NEDDylation in fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476699
Type at least 3 characters
1,645 articles
Articles
Correction
Published on 08 Nov 2024
Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404434
- 101 views
Original Research
Accepted on 07 Nov 2024
A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488722
Review
Published on 07 Nov 2024
Estrogen: the forgotten player in metaflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1478819
- 255 views
Original Research
Accepted on 06 Nov 2024
Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503648
Review
Published on 06 Nov 2024
P4HA1: an important target for treating fibrosis related diseases and cancer
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493420
- 167 views
Review
Published on 05 Nov 2024
The impact of diabetes mellitus on tendon pathology: a review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491633
- 127 views
Editorial
Published on 31 Oct 2024
Editorial: Chronic pain: what is the mechanism?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496510
- 148 views
Case Report
Published on 30 Oct 2024
Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472667
- 174 views
Review
Published on 29 Oct 2024
JAK inhibitors: an evidence-based choice of the most appropriate molecule
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494901
- 251 views
Editorial
Published on 28 Oct 2024
Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505196
- 138 views
Review
Published on 25 Oct 2024
Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488036
- 263 views
Review
Published on 23 Oct 2024
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491400
- 308 views
Mini Review
Published on 21 Oct 2024
Research progress of knee fibrosis after anterior cruciate ligament reconstruction
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493155
- 373 views
Clinical Trial
Published on 21 Oct 2024
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445708
- 464 views
Review
Published on 18 Oct 2024
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477680
- 417 views